BLV

BILIVERDIN IX GAMMA CHROMOPHORE

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
2 entries where BLV is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	77
Chiral Atom Count	0
Bond Count	80
Aromatic Bond Count	10

2D diagram of BLV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	BILIVERDIN IX GAMMA CHROMOPHORE
Systematic Name (OpenEye OEToolkits)	3-[5-[[5-[(Z)-[5-[[4-(2-carboxyethyl)-3-methyl-5-oxo-pyrrol-2-yl]methylidene]-4-ethenyl-3-methyl-pyrrol-2-ylidene]methyl]-4-ethenyl-3-methyl-1H-pyrrol-2-yl]methylidene]-4-methyl-2-oxo-pyrrol-3-yl]propanoic acid
Formula	C₃₃ H₃₄ N₄ O₆
Molecular Weight	582.646
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.341	CC1=C(CCC(O)=O)C(=O)NC1=Cc2[nH]c(C=C3NC(=CC4=NC(=O)C(=C4C)CCC(O)=O)C(=C3C)C=C)c(C=C)c2C
SMILES	OpenEye OEToolkits	1.5.0	Cc1c(c([nH]c1C=C2C(=C(C(=O)N2)CCC(=O)O)C)C=C3C(=C(C(=CC4=NC(=O)C(=C4C)CCC(=O)O)N3)C=C)C)C=C
Canonical SMILES	CACTVS	3.341	CC1=C(CCC(O)=O)C(=O)N\C1=C/c2[nH]c(\C=C3/N/C(=C\C4=NC(=O)C(=C4C)CCC(O)=O)C(=C3C)C=C)c(C=C)c2C
Canonical SMILES	OpenEye OEToolkits	1.5.0	Cc1c(c([nH]c1C=C2C(=C(C(=O)N2)CCC(=O)O)C)\C=C/3\C(=C(C(=CC4=NC(=O)C(=C4C)CCC(=O)O)N3)C=C)C)C=C
InChI	InChI	1.03	InChI=1S/C33H34N4O6/c1-7-20-16(3)24(13-26-18(5)22(32(42)36-26)9-11-30(38)39)34-28(20)14-25-17(4)21(8-2)29(35-25)15-27-19(6)23(33(43)37-27)10-12-31(40)41/h7-8,13-15,34-35H,1-2,9-12H2,3-6H3,(H,36,42)(H,38,39)(H,40,41)/b25-14-,26-13-,29-15-
InChIKey	InChI	1.03	ISQGGWQAVOHBFX-BGSBWKAWSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB02864
Name	Biliverdin Ix Gamma Chromophore
Groups	experimental
Synonyms	Biliverdin Ix Gamma Chromophore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.